Policy Notices

• Notice to Extend PA-18-795
  (NOT-HS-21-012)
  Agency for Healthcare Research and Quality
  

• Special Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Advance Health Equity
  (NOT-HS-21-014)
  Agency for Healthcare Research and Quality
  

• Implementation of Changes to the Biographical Sketch and Other Support Format Page
  (NOT-OD-21-110)
  National Institutes of Health
  

General Notices

• Guidance Regarding Reduction of Effort for Surgeons on NIA Individual Mentored K Awards
  (NOT-AG-21-019)
  National Institute on Aging
  

• Pre-application Webinar for RFA-CA-21-029, Centers for Telehealth Research for Cancer-Related Care (P50 Clinical Trial Required)
  (NOT-CA-21-073)
  National Cancer Institute
  

• Notice of Extension of the Expiration Date of PAR-19-159, "Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)"
  (NOT-EB-21-012)
  National Institute of Biomedical Imaging and Bioengineering
  National Cancer Institute
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Neurological Disorders and Stroke
  

• Notice of Information: Change in NCATS Prior Approval Process for New CTSA Program Pilot Projects and KL2 Projects that Involve Human Subjects Research
  (NOT-TR-21-026)
  National Center for Advancing Translational Sciences
  

• Request for Information: Response to Proposed NIH Sleep Disorders Research Plan Critical Opportunities and Strategic Goals
  (NOT-HL-21-011)
  National Heart, Lung, and Blood Institute
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  Office of Research on Women's Health
  

Notice of Changes to Funding Opportunities

• Notice of Change: Extension for PAR-18-820, "Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)"
  (NOT-AG-21-022)
  National Institute on Aging
  

• Notice of Change in Key Dates for RFA-AI-20-078, Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed)
  (NOT-AI-21-049)
  National Institute of Allergy and Infectious Diseases
  National Institute of Environmental Health Sciences
  

• Notice of NICHD Participation in RFA-AI-20-077 Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed)
  (NOT-HD-21-031)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice to Extend PA-18-794
  (NOT-HS-21-013)
  Agency for Healthcare Research and Quality
  

• Notice of Modification for RFA-MD-21-007, Centers for Multiple Chronic Diseases Associated with Health Disparities: Prevention, Treatment, and Management (P50 Clinical Trial Required)
  (NOT-MD-21-019)
  National Institute on Minority Health and Health Disparities
  

• Temporary Extension of Eligibility for the NINDS F32 Award Due the COVID-19 Pandemic
  (NOT-NS-21-059)
  National Institute of Neurological Disorders and Stroke
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Acquired Resistance to Therapy Network (ARTNet) (U54 Clinical Trial Not Allowed)
  (NOT-CA-21-063)
  National Cancer Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Coordinating and Data Management Center for Acquired Resistance to Therapy Network (ARTNet) (U24 Clinical Trial Not Allowed)
  (NOT-CA-21-064)
  National Cancer Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative Cell Atlas Network (BICAN): Comprehensive Center on Human and Non-human Primate Brain Cell Atlases (UM1 Clinical Trial Not Allowed)
  (NOT-MH-21-260)
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
  

• Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative Cell Atlas Network (BICAN): Specialized Collaboratory on Human, Non-human Primate, and Mouse Brain Cell Atlases (U01 Clinical Trial Not Allowed)
  (NOT-MH-21-261)
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
  

• Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE) (U24 Clinical Trial Not Allowed)
  (NOT-MH-21-262)
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
  

Notices of Special Interest

• Notice of Special Interest: National Cancer Institute Administrative Supplement Opportunity for Strategies to Optimize Recruitment and Retention of Cancer Prevention and Symptom Management Clinical Trial Participants
  (NOT-CA-21-070)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): Expanding Cancer Control Research in Persistent Poverty Areas
  (NOT-CA-21-071)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): Leveraging Longitudinal Studies in Animal Models to Identify Neural Mechanisms of Vulnerability and Resilience to Substance Use Disorder
  (NOT-DA-21-003)
  National Institute on Drug Abuse
  

• Notice of Special Interest (NOSI): Leveraging transformative connectome resources in model organisms to elucidate the neurobiology of substance use disorders
  (NOT-DA-21-006)
  National Institute on Drug Abuse
  

• RESCINDED - FDA Notice of Special Interest (NOSI) to add COVID-19 Capacity Building Grants to PAR-18-604 Vet-LIRN Network Capacity-Building Projects (Vet-LIRN)
  (NOT-FD-21-014)
  Food and Drug Administration
  

• Notice of Special Interest (NOSI): Reproductive Health, Pregnancy, and Parenting among Women with Disabilities
  (NOT-HD-21-025)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Special Interest (NOSI): Research on the Impact of the Covid 19 Pandemic and Risks for Abuse and Injury Among Vulnerable Children and Youth
  (NOT-HD-21-026)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

Funding Opportunities

• Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R43/R44 Clinical Trial Not Allowed)
  (PAR-21-225)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Standard dates apply The first standard due date for this FOA isSeptember 6, 2021
  
  

• Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R41/R42 Clinical Trial Not Allowed)
  (PAR-21-226)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Standard dates apply The first standard due date for this FOA is September 5, 2021
  
  

• Resource Center for the Support for Research Excellence (SuRE) Program (U24 - Clinical Trial Not Allowed)
  (PAR-21-227)
  National Institute of General Medical Sciences
  Application Receipt Date(s): September 24, 2021
  
  

• Systems Approach to Understand Mechanisms of Heterogeneous Response to Influenza (R01 Clinical Trial Not Allowed)
  (RFA-AI-21-017)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): September 08, 2021
  
  

• Mobile Health Solutions to rectify digital inequality in communities affected by drug addiction (R43/R44 Clinical Trial Optional)
  (RFA-DA-22-001)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 13, 2021
  
  

• Addressing Social Determinants of Health to Eliminate Oral Health Disparities (UG3/UH3 Clinical Trials Optional)
  (RFA-DE-22-002)
  National Institute of Dental and Craniofacial Research
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Research on Women's Health
  Application Receipt Date(s): July 08, 2021
  
  

• NIDDK Short-Term Research Experience Program to Unlock Potential (STEP-UP) (R25 Clinical Trial Not Allowed)
  (RFA-DK-21-023)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): September 1, 2021
  
  

• Pediatric and Perinatal COVID-19 Registry (U18) Clinical Trials Optional
  (RFA-FD-21-035)
  Food and Drug Administration
  Application Receipt Date(s): uly 6, 2021 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
  
  

• BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
  (RFA-MH-21-175)
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Translational Neural Devices (UG3/UH3 - Clinical Trial Optional)
  (RFA-NS-21-021)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Translational Neural Devices (U44 Clinical Trial Optional)
  (RFA-NS-21-022)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): July 1, 2021; October 20, 2021; February 18, 2022; June 20, 2022; October 18, 2022; February 21, 2023; June 19, 2023; October 18, 2023; February 20, 2024
  
  

• NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
  (RFA-RM-21-018)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): September 03, 2021